|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
Iteos Therapeutics, Inc. (ITOS) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
37,960,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$ - $ |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile iTeos Therapeutics is a clinical-stage biopharmaceutical company engaged in the discovery and development of a differentiated immuno-oncology therapeutics for patients. Co.'s product candidate, inupadenant, is designed as a selective small molecule antagonist of the adenosine A2a receptor, in the adenosine pathway, a main driver of immunosuppression in the tumor microenvironment across a range of tumors. Co.'s main antibody product candidate, EOS-448, is an antagonist of T-cell immunoreceptor with Ig and ITIM domains, an immune checkpoint with multiple mechanisms of action leading to immunosuppression.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
5,000 |
5,000 |
Total Buy Value |
$0 |
$0 |
$41,850 |
$41,850 |
Total People Bought |
0 |
0 |
1 |
1 |
Total Buy Transactions |
0 |
0 |
1 |
1 |
Total Shares Sold |
0 |
0 |
350,000 |
350,000 |
Total Sell Value |
$0 |
$0 |
$5,692,673 |
$5,692,673 |
Total People Sold |
0 |
0 |
1 |
1 |
Total Sell Transactions |
0 |
0 |
1 |
1 |
End Date |
2024-04-07 |
2024-01-05 |
2023-07-07 |
2022-07-07 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Mpm Asset Management Investors Bv2018 Llc |
10% Owner |
|
2021-10-15 |
4 |
AS |
$27.53 |
$301,937 |
I/I |
(10,932) |
3,141,158 |
|
- |
|
Mpm Bioventures 2018 Gp Llc |
10% Owner |
|
2021-10-15 |
4 |
AS |
$27.53 |
$301,937 |
I/I |
(10,932) |
3,141,158 |
|
- |
|
Oncology Impact Fund (cayman) Management L.p. |
10% Owner |
|
2021-10-15 |
4 |
AS |
$27.53 |
$505,300 |
I/I |
(18,295) |
5,147,534 |
|
- |
|
Oncology Impact Fund (cayman) Management L.p. |
10% Owner |
|
2021-10-14 |
4 |
AS |
$27.30 |
$1,248,129 |
I/I |
(45,719) |
5,165,829 |
|
- |
|
Mpm Bioventures 2018 Gp Llc |
10% Owner |
|
2021-10-14 |
4 |
AS |
$27.30 |
$745,836 |
I/I |
(27,320) |
3,152,090 |
|
- |
|
Mpm Asset Management Investors Bv2018 Llc |
10% Owner |
|
2021-10-14 |
4 |
AS |
$27.30 |
$745,836 |
I/I |
(27,320) |
3,152,090 |
|
- |
|
Oncology Impact Fund (cayman) Management L.p. |
10% Owner |
|
2021-10-13 |
4 |
AS |
$27.13 |
$950,174 |
I/I |
(35,023) |
5,211,548 |
|
- |
|
Mpm Bioventures 2018 Gp Llc |
10% Owner |
|
2021-10-13 |
4 |
AS |
$27.13 |
$567,804 |
I/I |
(20,929) |
3,179,410 |
|
- |
|
Mpm Asset Management Investors Bv2018 Llc |
10% Owner |
|
2021-10-13 |
4 |
AS |
$27.13 |
$567,804 |
I/I |
(20,929) |
3,179,410 |
|
- |
|
Oncology Impact Fund (cayman) Management L.p. |
10% Owner |
|
2021-10-12 |
4 |
AS |
$27.09 |
$386,303 |
I/I |
(14,260) |
5,246,571 |
|
- |
|
Mpm Bioventures 2018 Gp Llc |
10% Owner |
|
2021-10-12 |
4 |
AS |
$27.09 |
$230,834 |
I/I |
(8,521) |
3,200,339 |
|
- |
|
Mpm Asset Management Investors Bv2018 Llc |
10% Owner |
|
2021-10-12 |
4 |
AS |
$27.09 |
$230,834 |
I/I |
(8,521) |
3,200,339 |
|
- |
|
Gall Matthew |
Chief Financial Officer |
|
2021-10-11 |
4 |
OE |
$6.16 |
$88,883 |
D/D |
14,429 |
19,429 |
|
- |
|
Oncology Impact Fund (cayman) Management L.p. |
10% Owner |
|
2021-10-11 |
4 |
AS |
$27.24 |
$2,225,072 |
I/I |
(81,684) |
5,260,831 |
|
- |
|
Mpm Asset Management Investors Bv2018 Llc |
10% Owner |
|
2021-10-11 |
4 |
AS |
$27.24 |
$1,329,639 |
I/I |
(48,812) |
3,208,860 |
|
- |
|
Mpm Bioventures 2018 Gp Llc |
10% Owner |
|
2021-10-11 |
4 |
AS |
$27.24 |
$1,329,639 |
I/I |
(48,812) |
3,208,860 |
|
- |
|
Oncology Impact Fund (cayman) Management L.p. |
10% Owner |
|
2021-10-08 |
4 |
AS |
$27.01 |
$91,834 |
I/I |
(3,400) |
5,342,515 |
|
- |
|
Mpm Asset Management Investors Bv2018 Llc |
10% Owner |
|
2021-10-08 |
4 |
AS |
$27.01 |
$54,884 |
I/I |
(2,032) |
3,257,672 |
|
- |
|
Mpm Bioventures 2018 Gp Llc |
10% Owner |
|
2021-10-08 |
4 |
AS |
$27.01 |
$54,884 |
I/I |
(2,032) |
3,257,672 |
|
- |
|
Oncology Impact Fund (cayman) Management L.p. |
10% Owner |
|
2021-10-07 |
4 |
AS |
$27.00 |
$51,894 |
I/I |
(1,922) |
5,345,915 |
|
- |
|
Mpm Asset Management Investors Bv2018 Llc |
10% Owner |
|
2021-10-07 |
4 |
AS |
$27.00 |
$31,023 |
I/I |
(1,149) |
3,259,704 |
|
- |
|
Mpm Bioventures 2018 Gp Llc |
10% Owner |
|
2021-10-07 |
4 |
AS |
$27.00 |
$31,023 |
I/I |
(1,149) |
3,259,704 |
|
- |
|
Mpm Bioventures 2018 Gp Llc |
10% Owner |
|
2021-10-04 |
4 |
AS |
$27.06 |
$560,440 |
I/I |
(20,711) |
3,260,853 |
|
- |
|
Oncology Impact Fund (cayman) Management L.p. |
10% Owner |
|
2021-10-04 |
4 |
AS |
$27.06 |
$937,873 |
I/I |
(34,659) |
5,347,837 |
|
- |
|
Mpm Asset Management Investors Bv2018 Llc |
10% Owner |
|
2021-10-04 |
4 |
AS |
$27.06 |
$560,440 |
I/I |
(20,711) |
3,260,853 |
|
- |
|
229 Records found
|
|
Page 5 of 10 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|